Summary
Benzodiazepine dependence is a frequent complication of regular prescriptions for 4 weeks or longer, occurring in almost one-third of patients. Although it is also manifested by tolerance to drug effects and occasional drug seeking behaviour, particularly in those prone to drug abuse, most dependence is characterised by a withdrawal syndrome on stopping treatment. The withdrawal syndrome includes symptoms of anxiety and those of perceptual disturbance such as depersonalisation, hypersensitivity of all major senses, dysphoria and (rarely) epileptic seizures and psychotic episodes. Risk factors for dependence include high dosage, use of more potent and short acting benzodiazepines, long duration of therapy and dependent premorbid personality characteristics. If none of these apply, benzodiazepines can be prescribed with safety.
Similar content being viewed by others
References
Ashton CH, Rawlins MD, Tyrer SP. A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. British Journal of Psychiatry 157: 232–238, 1990
Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction 82: 665–671, 1987
Barnes GE. The alcoholic personality: a review of the literature. Journal of Studies on Alcohol 40: 571–634, 1979
Beaumont G. The use of benzodiazepines in general practice. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 141–152, John Wiley & Sons, Chichester, 1990
Brandon S. Clinical use of benzodiazepines in anxiety and panic disorders. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 111–139, John Wiley & Sons, Chichester, 1990
Busto U, Sellers E, Naranjo CA, Cappell H, Sanchez-Craig M, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315: 854–859, 1986
Butler G, Cullington A, Hibbert G, Klines I, Gelder M. Anxiety management for persistent generalised anxiety. British Journal of Psychiatry 151: 535–542, 1987
Cormack MA, Owens RG, Dewey ME. The effect of minimal interventions by general practitioners on long-term benzodiazepine use. Journal of the Royal College of General Practitioners 39: 408–411, 1989
Cowen PJ, Nutt DJ. Abstinence symptoms after withdrawal of tranquilising drugs: is there a common neurochemical mechanism? Lancet 2: 360–362, 1982
Fontaine R, Chouinard G, Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 141: 845–852, 1984
Greenblatt DJ, Shader RI, Divoll M, Harmatz BA. Benzodiazepines: a summary of pharmacokinetic properties. British Journal of Clinical Pharmacology 11: 115–165, 1981
Holton A, Riley P, Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. Journal of Affective Disorders 24: 245–252, 1992
King MB, Gabe J, Williams P, Rodrigo EK. Long-term use of benzodiazepines: the views of patients. British Journal of General Practice 40: 194–196, 1990
Lader M. History of benzodiazepine dependence. Journal of Substance Abuse Treatment 8: 53–59, 1991
Lader M, Beaumont G, Bond A, Butler G, Cobb J, et al. Guidelines for the management of patients with generalised anxiety. Psychiatric Bulletin 16: 560–565, 1992
Little HJ, Nutt DJ, Taylor SC. Bi-directional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor complex. Brain Research Reviews 19: 371, 1987
Marks J. The benzodiazepines: use, overuse, misuse, abuse, MTP Press, Lancaster, 1978
Miller NS, Gold MS. Benzodiazepines: a major problem. Introduction. Journal of Substance Abuse Treatment 8: 3–7, 1991
Munby M, Johnstone DW. Agoraphobia: the long-term followup of behavioural treatment. British Journal of Psychiatry 137: 418–427, 1980
Murphy SM, Owen RT, Tyrer PJ. Withdrawal symptoms after six weeks treatment with diazepam. Lancet 1: 1389, 1984
Murphy SM, Tyrer P. The essence of benzodiazepine dependence. In Lader (Ed.) The psychopharmacology of addiction, pp. 157–167, Oxford University Press, London, 1988
Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry 158: 511–516, 1991
Nutt DJ. Benzodiazepine dependence: New insights into basic research. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 19–41, John Wiley & Sons, Chichester, 1990
Onyett SR. The benzodiazepine withdrawal syndrome and its management. Journal of the Royal College of General Practioners, 39: 160–163, 1989
Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. British Medical Journal 283: 643–645, 1981
Power KG, Jerrom DWA, Simpson RJ, Mitchell M. Controlled study of withdrawal symptoms and rebound anxiety after six weeks course of diazepam for generalised anxiety. British Medical Journal 290: 1246–1248, 1985
Priest RG, Montgomery SA. Benzodiazepines and dependence: a College statement. Bulletin of the Royal College of Psychiatrists 12: 107–109, 1988
Rickels K, Case WG, Schweizer E, Garcia-Espana F, Fridman R. Benzodiazepine dependence: management of discontinuation. Psychopharmocology Bulletin 26: 63–68, 1989
Schweizer E, Clary C, Dever AI, Mandos LA. The use of low dose midazolam to treat panic disorder: a pilot study. Journal of Clinical Psychiatry 53: 19–22, 1992
Seivewright N, Dougal W. Withdrawal symptoms from high dose benzodiazepines in polydrug users. Drug and Alcohol Dependence 32: 15–23, 1993
Tesar GE. High potency benzodiazepine for short-term treatment of panic disorder: the US experience. Journal of Clinical Psychiatry 51: 4–10, 1990
Tyrer P. Dependence on benzodiazepines. British Journal of Psychiatry 137: 576–577, 1980
Tyrer P. Neurosis divisible?. Lancet 1: 685–688, 1985
Tyrer P. How to stop taking tranquillisers, Sheldon Press, London, 1986
Tyrer P. Dependence as a limiting factor in the clinical use of minor tranquillizers. Pharmacology and Therapeutics 36: 173–188, 1988
Tyrer P. Current problems with the benzodiazepines. In Wheatley (Ed.) The anxiolytic jungle: where next?, pp. 23–36, John Wiley, Chichester, 1990
Tyrer P. The nocebo effect: poorly known but getting stronger. In Dukes & Aronson (Eds) Side effects of drugs annual 15, pp. xix–xxv, Elsevier, Amsterdam, 1991a
Tyrer P. Qui devient dependant des benzodiazepines? In Venisse JL (Ed.) Les nouvelles addictions, pp. 142–147, Masson, Paris, 1991b
Tyrer P. Pharmacological differences between benzodiazepines. In Hallstrom (Ed.) Benzodiazepine dependence, Oxford University Press, London, 1993a
Tyrer P. Withdrawal from hypnotic drugs. British Medical Journal 305: 706–708, 1993b
Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1: 1402–1406, 1983
Tyrer P, Murphy S, Oates G, Kingdon D. Psychological treatment for benzodiazepine dependence. Lancet 1: 1042–1043, 1986
Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders 19: 53–61, 1990
Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1: 520–522, 1981
Tyrer P, Sievewright N. Identification and management of benzodiazepine dependence. Postgraduate Medical Journal 60: 41–46, 1984
Tyrer P, Seivewright N, Ferguson B, Tyrer J. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psychiatrica Scandinavica 85: 201–206, 1992
Winokur A, Rickels K, Greenblatt PJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long-term low dosage administration of diazepam. Archives of General Psychiatry 37: 101–105, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marriott, S., Tyrer, P. Benzodiazepine Dependence. Drug-Safety 9, 93–103 (1993). https://doi.org/10.2165/00002018-199309020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199309020-00003